Menu
Back to Journals » Cancer Management and Research » Volume 12
Original Research
Anlotinib Plus S-1 for Patients with EGFR Mutation-Negative Advanced Squamous Cell Lung Cancer with PS Scores of 2–3 After Progression of Second-Line or Later-Line Treatment
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 3,463 | Dovepress* | 3,182+ | 521 | 3,703 | |
| PubMed Central* | 281 | 113 | 394 | ||
| Totals | 3,463 | 634 | 4,097 | ||
| *Since 10 December 2020 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 3 | 0 | 0 | 0 | 1 | 2 |
View citations on PubMed Central and Google Scholar